Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Radiation-Related Cancer Risk Associated With Surveillance Imaging for Metastasis From Choroidal Melanoma

Radiation-Related Cancer Risk Associated With Surveillance Imaging for Metastasis From Choroidal... CLINICAL SCIENCES Radiation-Related Cancer Risk Associated With Surveillance Imaging for Metastasis From Choroidal Melanoma Joanne C. Wen, MD; Victor Sai, MD; Bradley R. Straatsma, MD, JD; Tara A. McCannel, MD, PhD Objective: To estimate the lifetime attributable risk of mated lifetime attributable risk of cancer of 0.9% for male cancer associated with whole-body positron emission to- patients and 1.3% for female patients, whereas an an- mography (PET)/computed tomography (CT) and with nual PET/CT each year for 10 years carries an estimated CT of the chest, abdomen, and pelvis if performed at vari- lifetime attributable risk of cancer of 1.6% for male pa- ous frequencies and for different durations for surveil- tients and 1.9% for female patients. Lifetime risk was found lance of patients with primary choroidal or ciliary body to be higher in younger, female patients. The lifetime at- melanoma for distant metastasis. tributable risk of cancer was estimated to be as high as 7.9% for a 20-year-old female patient receiving a PET/CT Methods: Effective radiation doses for whole-body CT scan every 6 months for 10 years. and for CT of the chest, abdomen, and pelvis were cal- culated using Monte Carlo simulation studies. The ef- Conclusions: Aggressive surveillance http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Radiation-Related Cancer Risk Associated With Surveillance Imaging for Metastasis From Choroidal Melanoma

Download PDF
6 pages
Read Article

Loading next page...
 
/lp/american-medical-association/radiation-related-cancer-risk-associated-with-surveillance-imaging-for-jwla9lQPpg
Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/jamaophthalmol.2013.564
pmid
23307209
Publisher site
See Article on Publisher Site

Abstract

CLINICAL SCIENCES Radiation-Related Cancer Risk Associated With Surveillance Imaging for Metastasis From Choroidal Melanoma Joanne C. Wen, MD; Victor Sai, MD; Bradley R. Straatsma, MD, JD; Tara A. McCannel, MD, PhD Objective: To estimate the lifetime attributable risk of mated lifetime attributable risk of cancer of 0.9% for male cancer associated with whole-body positron emission to- patients and 1.3% for female patients, whereas an an- mography (PET)/computed tomography (CT) and with nual PET/CT each year for 10 years carries an estimated CT of the chest, abdomen, and pelvis if performed at vari- lifetime attributable risk of cancer of 1.6% for male pa- ous frequencies and for different durations for surveil- tients and 1.9% for female patients. Lifetime risk was found lance of patients with primary choroidal or ciliary body to be higher in younger, female patients. The lifetime at- melanoma for distant metastasis. tributable risk of cancer was estimated to be as high as 7.9% for a 20-year-old female patient receiving a PET/CT Methods: Effective radiation doses for whole-body CT scan every 6 months for 10 years. and for CT of the chest, abdomen, and pelvis were cal- culated using Monte Carlo simulation studies. The ef- Conclusions: Aggressive surveillance

Journal

JAMA Ophthalmology – American Medical Association

Published: Jan 1, 2013

References

  • Prognostic parameters in uveal melanoma: a review.
    Mooy, CM; De Jong, PT
  • Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.
    Diener-West, M; Reynolds, SM; Agugliaro, DJ
  • Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15.
  • Effectiveness of treatments for metastatic uveal melanoma.
    Augsburger, JJ; Corrêa, ZM; Shaikh, AH
  • Predictive power of screening tests for metastasis in uveal melanoma.
    Hicks, C; Foss, AJ; Hungerford, JL
  • Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23.
    Diener-West, M; Reynolds, SM; Agugliaro, DJ
  • Screening for metastatic malignant melanoma of the uvea revisited.
    Eskelin, S; Pyrhönen, S; Summanen, P; Prause, JU; Kivelä, T
  • Whole body PET/CT for initial staging of choroidal melanoma.
    Finger, PT; Kurli, M; Reddy, S; Tena, LB; Pavlick, AC
  • Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
    Kurli, M; Reddy, S; Tena, LB; Pavlick, AC; Finger, PT
  • Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients.
    Freton, A; Chin, KJ; Raut, R; Tena, LB; Kivelä, T; Finger, PT
  • Review of diagnostic imaging modalities for the surveillance of melanoma patients.
    Xing, Y; Cromwell, KD; Cormier, JN
  • Cancer risks from diagnostic radiology.
    Hall, EJ; Brenner, DJ
  • Health Risks From Exposure to Low Levels of Ionizing Radiation: BEIR VII—Phase 2.
  • Sources and Effects of Ionizing Radiation: United Nations Committee on the Effects of Atomic Radiation: UNSCEAR 1993 Report to the General Assembly, With Scientific Annexes.
  • Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography.
    Einstein, AJ; Henzlova, MJ; Rajagopalan, S
  • Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast.
    O'Connor, MK; Li, H; Rhodes, DJ; Hruska, CB; Clancy, CB; Vetter, RJ
  • Radiation risks from exposure to chest computed tomography.
    Huppmann, MV; Johnson, WB; Javitt, MC
  • Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography.
    Tarin, TV; Sonn, G; Shinghal, R
  • Estimated radiation risks potentially associated with full-body CT screening.
    Brenner, DJ; Elliston, CD
  • Whole-body PET/CT scanning: estimation of radiation dose and cancer risk.
    Huang, B; Law, MW; Khong, PL
  • NRPB-SR250: normalised organ doses for x-ray computed tomography calculated using Monte Carlo techniques.
    Jones, DG; Shrimpton, PC
  • Radiation dose to patients from radiopharmaceuticals: addendum 3 to ICRP Publication 53: ICRP Publication 106: approved by the commission in October 2007.
  • 1990 Recommendations of the International Commission on Radiological Protection.
  • Radiation-epidemiological studies of thyroid cancer incidence in Russia after the Chernobyl accident (estimation of radiation risks, 1991-2008 follow-up period).
    Ivanov, VK; Kashcheev, VV; Chekin, SY
  • Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990.
    Land, CE; Tokunaga, M; Koyama, K
  • Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.
    Brix, G; Lechel, U; Glatting, G
  • Estimating prognosis for survival after treatment of choroidal melanoma.
    Damato, B; Eleuteri, A; Taktak, AF; Coupland, SE
  • Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases.
    Shields, CL; Kaliki, S; Furuta, M; Mashayekhi, A; Shields, JA
  • Detection of metastatic disease in patients with uveal melanoma using positron emission tomography.
    Francken, AB; Fulham, MJ; Millward, MJ; Thompson, JF
  • Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma.
    Strobel, K; Bode, B; Dummer, R
  • (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
    Orcurto, V; Denys, A; Voelter, V
  • Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.
    Antoch, G; Vogt, FM; Freudenberg, LS
  • Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival.
    Augsburger, JJ; Corrêa, ZM; Trichopoulos, N

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

Sign up
for free
Start 14 day
Free Trial